Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 3 , Pages 401-411, June 2009

The impact of glucose-lowering therapy on cardiovascular outcomes

Munich Diabetes Research Institute at the Munich Helmholtz Center, Ingolstädter Landstrasse 1, 85 764 Munich Neuherberg, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(09)00029-3

doi:10.1016/j.beem.2009.03.010

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 3 , Pages 401-411, June 2009

Article Tools